Avectas
Aisling McCrudden is an experienced analytical scientist currently employed at Avectas since April 2023. Prior to this role, Aisling served as a platform development scientist at RemedyBio from April 2021 to April 2023, where responsibilities included the creation and maintenance of a biobank and the optimization and validation of bio-assays. Earlier, Aisling held positions as a laboratory technician and research assistant in various settings, including Trinity College Dublin, where duties involved lab management and research in immunometabolism, as well as experience with flow cytometry and cell culture. Aisling earned a Bachelor of Science in Human Health & Disease from Trinity College Dublin and a Level 9 Certificate in Biopharmaceutical Science from the Institute of Technology, Sligo.
This person is not in any offices
Avectas
1 followers
Avectas is a cell engineering business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene-modified cell therapy products, with partners.